A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®

Condition:   18-42 Year Old Healthy Vaccinia-naïve SubjectsInterventions:   Biological: MVA BN®;   Biological: ACAM2000®Sponsors:   Bavarian Nordic;   United States Army Medical Research Institute of Infectious DiseasesRecruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials